DEBM_CompanyBanner_International_LG

Debiopharm International S.A.


developing &
financing
innovative
drugs

Business

Discover our Pipeline

15 programs from discovery to phase III

Discover
Latest news
September 3, 2019

Debiopharm successfully completes randomized Phase II study for IAP antagonist Debio 1143 in high risk head & neck cancer patients

Read more
July 9, 2019

Debiopharm and BIOASTER join forces to expand research to combat infectious diseases

Read more
See all news
Agenda
Let's meet

ESMO 2019

September 27 - October 1, 2019 Barcelona, Spain Discover
Debiopharm-Event-ESMO 2019
See all events

Business model

Your candidates turned into solutions for patients

In-licensing Deal Focus

You want to partner with us? Discover what kind of projects we look for

Partners
Universities, Biotech, Big pharma
Main areas
Oncology, Infectious Diseases
Development stages
From candidate to clinical phase II
Molecules
Small molecules, antibodies and peptides
Debiopharm-Bertrand-Ducrey
Management

Discover the members who guide and bring long-term vision to the company

Discover
Press releases

Latest Debiopharm International's announcements for media and journalists

Learn more
Publications

Discover Debiopharm International's latest publications and posters

Read more
Contact us

Would like to partner with us? Got a question or a comment? Get in touch!

Get in touch